Clinical Research Biologics

The Pinnacle of
Regenerative Medicine.

Redicell Biologics provides specialized, cGMP-grade stem cells, targeted progenitor cells, mitochondria, and exosomes. Explore our comprehensive biologic portfolio for your clinical and research needs.

Important Regulatory Notice

All products are strictly for international and research approved use only. Clinic or institutional registration is required prior to pricing access and fulfillment.

View Catalog

Uncompromising Quality & Sourcing

At Redicell, we exclusively use Umbilical Cord Tissue-derived Mesenchymal Stem Cells (UCT-MSCs). This perinatal source provides the optimal balance of potency, safety, and ethical consideration.

👩‍⚧️

Premium Donors

Exclusively sourced from healthy, first-pregnancy mothers aged 18-28 via scheduled cesarean births with informed consent.

🔬

Rigorous Screening

Extensive maternal blood work, 3-generation family history checks, normal female karyotyping (46, XX), and verification of pathogen-free status.

🛡

Pre-Pandemic Origin

All umbilical cord tissue is sourced from pre-COVID births for an unparalleled level of additional safety assurance.

🧪

cGMP Processing

Cultured in bovine serum-free media. Cryopreserved using a proprietary glucose-based method (DMSO-free), ensuring >95% viability.

Why Redicell's UCT-MSCs Outperform Alternatives

Comparing traditional stem cell sources against our advanced perinatal methodology.

Stem Cell Source Standard Limitations The Redicell Solution
Bone Marrow MSCs (Autologous) Invasive collection, aged cells, reduced differentiation capacity in older patients. Young, potent UCT-MSCs with superior expansion capacity and longer telomeres.
Adipose MSCs (Autologous) Lower purity, risk of contamination during liposuction, highly variable quality based on patient health. Highly pure, consistently manufactured cell populations with immune-privilege (low MHC II).
Cord Blood Extremely limited MSC yield, higher immunogenicity risks. Wharton's Jelly tissue provides abundant MSCs with enhanced immune privilege properties.
iPSCs (Induced Pluripotent) Significant risk of genetic mutation and teratoma (tumor) formation. Natural multipotent cells with a stable genome and proven safety profile.

Clinical Therapeutics Catalog

Browse our complete inventory of cellular lines, exosomes, and secretomes. Add desired products to your inquiry cart. Contact us for pricing.

🔍

Therapeutic Categories

🛒 Inquiry Cart

Review items to request pricing

Submitting this inquiry will generate a formal PO email to office@redicell.com. Our team will contact you with pricing and availability.